Subscribe To

Price Alert Latest News Economic Calendar News

QGEN / Qiagen N.V. (QGEN) Q1 2023 Earnings Call Transcript

Qiagen N.V. (NYSE:QGEN ) Q1 2023 Earnings Conference Call May 4, 2023 9:00 AM ET Company Participants John Gilardi – Vice President, Head of Corporate Communications and Investor Relations Thierry Bernard – Chief Executive Officer Roland Sackers – Chief Financial Officer Conference Call Participants Andrew Brackmann – William Blair Aisyah Noor – Morgan Stanley Dan Arias – Stifel Odysseas Manesiotis – Berenberg Dan Brennan – TD Cowen Casey Woodring – JPMorgan Patrick Donnelly – Citi John Sourbeer – UBS Operator Ladies and gentlemen, thank you for standing by. Read More

Demo Live Account See Partner Details

Content Topics

Qiagen

QGEN

2023

Earnings

Call

Transcript

qgen

Stock

Posted: May 4 2023, 15:17

Author Name: Seeking Alpha

QGEN News

By Zacks Investment Research
October 31, 2023

QIAGEN (QGEN) Q3 Earnings and Revenues Beat, Margins Down

In an increasingly challenging macro environment, QIAGEN (QGEN) surpasses the earnings and revenue outlook in the third quarter of 2023.

By Zacks Investment Research
October 30, 2023

Qiagen (QGEN) Reports Q3 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for Qiagen (QGEN) give a sense of how its business performed in the quarter ended September 2023, it might be worth consi

By Zacks Investment Research
October 30, 2023

Qiagen (QGEN) Q3 Earnings and Revenues Surpass Estimates

Qiagen (QGEN) came out with quarterly earnings of $0.50 per share, beating the Zacks Consensus Estimate of $0.49 per share. This compares to earnings

By Zacks Investment Research
October 18, 2023

Here's Why You Should Retain QIAGEN (QGEN) Stock for Now

Investors are optimistic about QIAGEN's (QGEN) growth in the molecular diagnostics business and the latest acquisition.

By Zacks Investment Research
September 26, 2023

QIAGEN (QGEN) Extends QIAwave Product Line With New Kit

QIAGEN's (QGEN) new QIAwave kits broaden its selection of environmentally friendly products and reaffirm its commitment to helping researchers advance

By Seeking Alpha
August 9, 2023

Qiagen NV (QGEN) Q2 2023 Earnings Call Transcript

Qiagen NV (NYSE:QGEN ) Q2 2023 Earnings Conference Call August 9, 2023 9:00 AM ET Company Participants John Gilardi - VP, Corporate Communications & I

By Zacks Investment Research
August 9, 2023

QIAGEN (QGEN) Q2 Earnings and Revenues Top, '23 View Slashed

QIAGEN (QGEN) surpasses the earnings and revenue outlook in the second quarter of 2023 amid a challenging macro environment.

By Zacks Investment Research
August 8, 2023

Qiagen (QGEN) Surpasses Q2 Earnings and Revenue Estimates

Qiagen (QGEN) came out with quarterly earnings of $0.51 per share, beating the Zacks Consensus Estimate of $0.50 per share. This compares to earnings

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.